| Net Cash Provided by (Used in) Operating Activities |
$0 |
USD |
-100% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$0 |
USD |
-100% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
75,000,000 |
shares |
|
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
4,558,063 |
shares |
|
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$0 |
USD |
-100% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$23,767 |
USD |
24% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$107,769 |
USD |
9.8% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Liability |
$0 |
USD |
|
Q3 2024 |
Q3 2024 |
| Operating Lease, Liability, Current |
$0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$107,769 |
USD |
9.8% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$169,072 |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Current Federal Tax Expense (Benefit) |
$508,320 |
USD |
6% |
Q1 2025 |
Q1 2025 |
| Depreciation, Depletion and Amortization |
$36,160 |
USD |
418% |
Q1 2024 |
Q1 2024 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q3 2025 |
Q3 2025 |